HEMISPHERX BIOPHARMA INC (HEB) Stock Analyst Ratings

NYSEARCA:HEB

1.8
-0.01 (-0.55%)
At close: Aug 30, 2019
1.77
-0.03 (-1.67%)
After Hours: 8/30/2019, 8:05:43 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Buy % Consensus

60

ChartMill assigns a Buy % Consensus number of 60% to HEB. The Buy consensus is the weighted average rating of the current analysts ratings.

  • HEB was analyzed by 1 analysts. The buy percentage consensus is at 60. So analysts seem to be rather neutral about HEB.
  • In the last month the buy percentage fell by 40 points. So the trust of analysts is decreasing.
  • Only 1 analysts analyzed HEB. So this is just the average opinion of a couple of analysts.

Related screens

Find peers with buy consensus above 85%
HEB Historical Analyst RatingsHEB Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -8 -7 -6 -5 -4 -3 -2 -1 0 0.2 0.4 0.6 0.8
HEB Current Analyst RatingHEB Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.2 0.4 0.6 0.8
Up and Down Grades

HEMISPHERX BIOPHARMA INC / HEB FAQ

Can you provide the consensus rating for HEMISPHERX BIOPHARMA INC stock?

The consensus rating for HEMISPHERX BIOPHARMA INC (HEB) is 60 / 100 . This indicates that analysts generally have a neutral outlook on the stock.


What is the number of analysts for HEB stock?

The number of analysts covering HEMISPHERX BIOPHARMA INC (HEB) is 1.